HIA
ABMD

Harbor Investment Advisory’s Abiomed Inc ABMD Stock Holding History

Harbor Investment Advisory’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10
Closed -$2K – 1266
2020
Q2 		$2K Sell
10
-35
-78% -$7.03K ﹤0.01% 1026
2020
Q1 		$7K Sell
45
-15
-25% -$2.49K ﹤0.01% 819
2019
Q4 		$10K Buy
+60
New +$11.1K ﹤0.01% 644

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbor Investment Advisory's ABMD Position: Q3 2020 in Review

Harbor Investment Advisory sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 10 shares — an estimated $2K sold.

Harbor Investment Advisory first reported a position in ABMD in Q4 2019 and held it in 3 quarters. The position peaked at $10K in Q4 2019. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • Harbor Investment Advisory reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
  • Harbor Investment Advisory sold 10 Abiomed Inc shares in Q3 2020, an estimated $2K.
  • Harbor Investment Advisory first reported a position in Abiomed Inc in Q4 2019 and held it in 3 quarters.
  • Harbor Investment Advisory's Abiomed Inc position peaked at $10K in Q4 2019.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on Harbor Investment Advisory's 13F filing for Q3 2020, filed 23 Oct 2020.